CervoMed Inc. Investing Cash Flow
CervoMed Inc. (CRVO) reported Investing Cash Flow of $10.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- CervoMed Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $2.53M.
- CervoMed Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $7.71M, a 42.88% increase year-over-year.
- CervoMed Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $5.37M, a 42.26% decline year-over-year.
- CervoMed Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $7.58M, a 191.34% increase year-over-year.
- CervoMed Inc. net cash provided by (used in) investing activities for fiscal 2025 was $18.10M.
- CervoMed Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$28.66M.
- CervoMed Inc. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- CervoMed Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$12.24M, a 305993.45% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.24M 10-Q · filed 2026-08-07 | $15.61M derived: sum of 3 quarters · filed 2026-08-07 | $23.19M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $7.71M 10-Q · filed 2026-05-15 | $13.08M derived: sum of 2 quarters · filed 2026-05-15 | $20.67M derived: sum of 3 quarters · filed 2026-05-15 | $20.41M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $12.96M derived: sum of 2 quarters · filed 2026-03-13 | $12.70M derived: sum of 3 quarters · filed 2026-08-07 | $18.10M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $7.33M derived: sum of 2 quarters · filed 2026-08-07 | $12.72M 10-Q · filed 2025-11-07 | $22.03M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$254.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.14M 10-Q · filed 2026-08-07 | $14.45M derived: sum of 3 quarters · filed 2026-08-07 | $17.05M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $5.40M 10-Q · filed 2026-05-15 | $14.70M derived: sum of 2 quarters · filed 2026-05-15 | $17.31M derived: sum of 3 quarters · filed 2026-05-15 | -$23.26M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $11.91M derived: sum of 2 quarters · filed 2026-03-13 | -$28.66M derived: sum of 3 quarters · filed 2026-03-13 | -$28.66M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$37.97M derived: sum of 2 quarters · filed 2025-11-07 | -$37.97M 10-Q · filed 2025-11-07 | -$37.97M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$40.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$40.57M 10-Q · filed 2025-08-08 | -$40.57M derived: sum of 3 quarters · filed 2025-08-08 | -$40.57M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-12 | -$9.50M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | -$9.50M derived: sum of 3 quarters · filed 2025-03-17 | $0.00 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$9.50M derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $7.00M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $12.50M 10-Q · filed 2023-08-08 | $7.00M derived: sum of 3 quarters · filed 2024-08-09 | $10.38M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $9.50M 10-Q · filed 2023-05-15 | $16.50M derived: sum of 2 quarters · filed 2023-05-15 | $19.88M derived: sum of 3 quarters · filed 2023-05-15 | $19.98M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $10.38M derived: sum of 2 quarters · filed 2023-03-24 | $10.48M derived: sum of 3 quarters · filed 2023-08-08 | -$12.24M 10-K · filed 2023-03-24 | ||||
| 2022-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.48M derived: sum of 2 quarters · filed 2023-08-08 | -$19.24M 10-Q · filed 2022-11-14 | -$19.23M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-06-30 | $100.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$22.62M 10-Q · filed 2023-08-08 | -$22.61M derived: sum of 3 quarters · filed 2023-08-08 | -$22.61M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$22.72M 10-Q · filed 2023-05-15 | -$22.71M derived: sum of 2 quarters · filed 2023-05-15 | -$22.71M derived: sum of 3 quarters · filed 2023-05-15 | -$22.71M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $4.00K derived: sum of 2 quarters · filed 2023-03-24 | $4.00K derived: sum of 3 quarters · filed 2023-03-24 | $4.00K 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-18 | |||||||
| 2017-12-31 | $9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $9.62M derived: sum of 2 quarters · filed 2019-03-19 | -$441.45K derived: sum of 3 quarters · filed 2019-03-19 | -$447.82K 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | -$374.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$10.43M derived: sum of 2 quarters · filed 2018-11-13 | -$10.44M 10-Q · filed 2018-11-13 | -$10.44M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$10.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$10.06M 10-Q · filed 2018-08-10 | -$10.06M derived: sum of 3 quarters · filed 2018-08-10 | -$10.06M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | -$6.37K 10-Q · filed 2018-05-10 | -$6.37K derived: sum of 2 quarters · filed 2018-05-10 | -$6.37K derived: sum of 3 quarters · filed 2018-05-10 | -$6.71K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | -$337.00 derived: sum of 3 quarters · filed 2018-04-02 | $8.50M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$337.00 derived: sum of 2 quarters · filed 2017-11-13 | $8.50M 10-Q · filed 2017-11-13 | $8.47M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | -$337.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $8.50M 10-Q · filed 2017-08-14 | $8.47M derived: sum of 3 quarters · filed 2017-08-14 | $8.47M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $8.50M 10-Q · filed 2017-05-15 | $8.47M derived: sum of 2 quarters · filed 2017-05-15 | $8.47M derived: sum of 3 quarters · filed 2017-05-15 | $8.46M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$26.65K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$29.35K derived: sum of 2 quarters · filed 2017-03-31 | -$38.11K derived: sum of 3 quarters · filed 2017-03-31 | $2.46M 10-K · filed 2017-03-31 | -$278.23K 10-K · filed 2016-03-25 | |||
| 2015-09-30 | -$2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$11.46K derived: sum of 2 quarters · filed 2016-11-14 | $2.49M 10-Q · filed 2016-11-14 | -$278.23K 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | -$8.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $2.49M 10-Q · filed 2016-08-15 | -$278.23K 10-Q · filed 2015-08-12 | |||||
| 2015-03-31 | $2.50M 10-Q · filed 2016-05-16 | -$19.23K 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | -$50.91K 10-K · filed 2016-03-25 | |||||||
| 2011-12-31 | $5.58K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | -$61.83K derived: sum of 2 quarters · filed 2013-04-24 | -$985.89K 10-K/A · filed 2013-04-24 | |||||
| 2011-09-30 | -$67.41K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -$991.47K 10-Q · filed 2012-11-19 | ||||||
| 2011-06-30 | -$924.07K 10-Q/A · filed 2012-09-07 | |||||||
| 2010-12-31 | -$668.78K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | -$808.72K derived: sum of 2 quarters · filed 2012-05-21 | -$1.38M 10-K · filed 2012-05-21 | |||||
| 2010-09-30 | -$139.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$715.66K 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | -$575.72K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |